1HIV and Hepatitis Research Center, Shiraz University of Medical Sciences, Gerash, IR Iran
2Biotechnology Research Center, Pasteur Institute of Iran, Tehran, IR Iran
*Corresponding Author: HIV and Hepatitis Research Center, Shiraz University of Medical Sciences, Gerash, IR Iran, [email protected]. Email: [email protected]
Archives of Clinical Infectious Diseases:Vol. 3, issue 4; 215-9
Published online:Oct 31, 2008
Article type:Brief Report
How to Cite:Bahmani MK, Khosravi A, Mahboodi F, SarramiForooshani R. Genotypic Correlation of a Virologic Response to Lamivudine, Stavudine and Nevirapine in Patients for Whom Combination Therapy Had Failed. Arch Clin Infect Dis. 2008;3(4):. doi:
Abstract
Background:
Resistance is the consequence of mutations that emerge in the viral proteins targeted by antiretroviral agents. Thus, we focused our attention on mutations in HIV-1 reverse transcriptase to define their association with specific NRTIs and NRTI resistance mutations at therapeutic failure.
Patients and methods:
The study population included 5 Iranian HIV-positive patients referring to Counseling Behavioral Modification Center in Shiraz who received a combination of antiretroviral therapy (lamivudine, stavudine and nevirapine). PBMC DNA was isolated from blood and PCR was performed to produce a 1200 bp amplicon and resolved by electrophoresis on a 0.7% agarose TBE gel, visualized with ethidium bromide. PCR products from HIV-1- infected patients were cloned into pCR2.1TOPO, then sequenced. Finally, sequence data were analyzed.
Results:
Results showed drug resistance in 2 patients, of whom one had NNRTI resistance mutations (M230G, L234R and K238H) and other had both NRTI (V75M) and NNRTI (F227L) resistance mutations.
Conclusion:
Confirmation of genetic resistance in HIV-positive patients who show therapy failure can help physicians to change their drug regime in order to achieve better outcome.
Seyed Alinaghi SA, Rasoolinejad M, Najafi Z, Dadras O, Malekianzadeh E, et al. Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran. Arch Clin Infect Dis. 2019;14(6):e96531. doi: https://doi.org/10.5812/archcid.96531
Shahzamani K, Sabzali S, Moetamedi S, Birjandi M, Zavari T. Exploring Virological Failure in HIV/AIDS Treatment: A Cross-sectional Study of Antiretroviral Regimen Efficacy and Predictors in Khorramabad City During 2011 - 2021. Jundishapur J Microbiol. 2026;19(5):e167579. doi: https://doi.org/10.5812/jjm-167579
Talei GR, Heydarifard Z, Khanizadeh S. Exploring Drug-Resistant Mutations in Protease Inhibitors and Subtype Distribution Among HIV-1 Positive Patients in Lorestan Province, Iran. Jundishapur J Microbiol. 2024;17(3):e145562. doi: https://doi.org/10.5812/jjm-145562
Rasoolinejad M, Sarraf M, Najafi Z, SeyedAlinaghi S, Moradmand Badie B, et al. Virologic Failure in Different Antiretroviral Regimens Among Pediatric Patients with HIV Referring to a Voluntary Counseling and Testing (VCT) Center in Tehran, Iran (2004 - 2017). Arch Pediatr Infect Dis. 2019;7(4):e80318. doi: https://doi.org/10.5812/pedinfect.80318